We identified which LAA (WT-1, PRAME, or NPM-1) generated the strongest immune response (as measured by colony-forming immunoassays) and using samples from 20 AML patients with more than 90% leukemic blasts. The gene discussed is NPM1; the disease is acute myeloid leukemia.